Skip to main content

Table 2 Biochemical markers and characteristics (mean ± SD) of bone metabolism of the male HIV-1 infected patients with hypogonadism (group I); (significance between HIV-1 infected men of group I or II and controls * p < 0.05) (significance between hypogonadal and eugonadal patients # p < 0.05)

From: Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)

Parameter Group I
(n = 32)
Group II
(n = 48)
Group III
(n = 20)
Range
  HIV-1
Hypogonadism
HIV-1
Eugonadism
male controls  
Serum Ca [mmol/l] 2.10 ± 0.107 * 2.21 ± 0.1 2.6 ± 0.23 2.20-2.65 [mmol/l]
Serum D 1,25(OH2)D [pg/ml] 27.9 ± 9.7 * 31.5 ± 7.5 * 67.45 ± 4.25 44-74 [pg/ml]
Serum D 25(OH)D [ng/ml] 24.3 ± 10.3 *# 46.7 ± 14.1 * 69.5 ± 13.5 8-80 [ng/ml]
PTH [pg/ml] 19.6 ± 8.9 * 28.5 ± 5.2 * 37.8 ± 4.8 10-65 [pg/ml]
Osteocalcin [ng/ml] 2.35 ± 0.57 * # 3.58 ± 0.53 3.6 ± 0.39 2.0-6.5 [ng/ml]
Creatinine [mg/dl] 0.89 ± 0.1 0.99 ± 0.14 0.87 ± 0.15 0.68-1.09 mg/dl
Albumine [g/l] 38.9 ± 6.2 41.3 ± 5.7 46.5 ± 3.7 35.8-50.6 [g/l]
Crosslinks [nmol/pyd/mmol Crea] 79.0 ± 11.7 *# 65.71 ± 10.2 31.5 ± 6.2 < 50
Urinary Ca [mmol/24 h] 7.72 ± 0.75 *# 4.47 ± 0.69 1.07 ± 0.31 < 6.2 [mmol/l]